Breathe Well Live Well
 Minyanville.com |
GlaxoSmithKline Ties Up Loose Ends With Relovair
Minyanville.com The FDA recently made more stringent requirements for drugs that contain long-acting beta agonists for the treatment of asthma due to safety concerns. … Glaxo, Theravance report Relovair safety data GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results GSK and Theravance announce combination ICS/LABA Phase II results in the … |
View full post on asthma – Google News
|
Phuket oil scare ends; Phuket probes asthma
Phuket Gazette – A daily digest of news about Thailand from around the world, compiled by Gazette editors for Phuket's international community. PHUKET: A Phuket provincial … |
View full post on asthma – Google News
 Stockopedia |
Skyepharma slides as US group ends asthma drug deal
The Guardian Shares in Skyepharma have fallen around 5% after another setback for its asthma treatment flutiform. The company has announced that Abbott Laboratories has … SkyePharma loses US partner Abbot shelves interest in SkyePharma's Flutiform SkyePharma says Abbott ends US Flutiform deal |
View full post on asthma – Google News